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Abstract
Major aetiologies of atherosclerotic cardiovascular diseases begin in childhood and ath-
erosclerotic vascular abnormalities can be observed among children and adolescents.
Adolescent cohort studies have important advantages because they can observe earlier
changes in vascular structure and function. The purpose of the JS High School study
(JSHS) is to identify biomarkers predicting or indicating early structural and functional
vascular change in adolescents. The JSHS is a prospective cohort study of a Korean ado-
lescent population. The target population of the JSHS was first-graders (aged 14
to17 years) at a high school of South Korea. Enrolment and baseline examinations were
conducted in years 2007, 2010, 2011 and 2012. Among the total eligible population of 1115
students, 1071 (96.1%) participated in the study and completed all baseline examinations.
Informed consent forms were obtained from each participant and his/her parent or guard-
ian. Baseline examinations include: questionnaires on demographics, health behaviours,
medical history, and depression symptoms; fasting blood analysis; anthropometric meas-
urement; body impedance analysis; blood pressure measurement; radial artery tonometry;
bone densitometry; pulmonary function tests; and carotid ultrasonography. Participants en-
rolled from 2007 through 2012 were re-examined after 30 months of follow-up, and those
who enrolled in 2012 were re-examined after 24 months of follow-up. The corresponding
author may be contacted for potential collaboration and data access.
Key Messages
• Higher blood pressure may be associated with atherosclerotic change in adolescents.
• Higher pulse pressure may be associated with atherosclerotic change in healthy male adolescents.
• Lower serum vitamin D concentration may be associated with insulin resistance in healthy male adolescents.
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Why was the study set up?
Although most apparently healthy adolescents are free of
atherosclerotic vascular changes, some adolescents may
present accelerated vascular change because of the pres-
ence of risk factors or specific diseases.1 Several epidemio-
logical studies have reported that the major aetiologies of
atherosclerotic vascular diseases may begin in childhood
and atherosclerotic vascular abnormalities can be observed
among children and adolescents.2–9 Autopsy studies of
children and young adults who have died from non-cardio-
vascular causes have also demonstrated direct evidence of
the early development of atherosclerosis, with findings of
fatty streaks10 and fibrous plaque.11–13 In children and
adolescents, indirect evidence for early development of ath-
erosclerosis has been found in studies that detected vascu-
lar changes associated with cardiovascular disease in
adulthood.14–19 These include changes in vessel anatomy,
as well as mechanical changes and physiological changes.15
Adolescent cohort studies have an important advantage be-
cause they can observe earlier changes in vascular structure
and function. Adolescent cohorts are also helpful when
investigating new biomarkers and risk factors, because
their study populations are less exposed to major vascular
risk factors.
Over the past several decades, the Korean population
has experienced a rapid epidemiological transition in car-
diovascular disease.20 Moreover, obesity and cardiovascu-
lar risk factors are becoming more prevalent among
Korean children and adolescents.21,22 Accordingly, athero-
sclerotic cardiovascular disease is expected to become a
bigger health problem in the future. Thus, it is important
to assess the cardiovascular risk profiles of Korean adoles-
cents and their impact on cardiovascular disease later in
life. However, early vascular changes and associated fac-
tors remain largely understudied in Korea. The JS High
School study (JSHS) is a prospective cohort study aiming
to observe earlier change in vascular structure and function
in Korean adolescents, as well as identify its predictors
thereof.
Who is in the cohort?
We recruited an adolescent cohort that consists of first-
year students at a high school in a rural community of
South Korea. Enrolment and baseline examinations were
conducted in April 2007, June 2010, June 2011 and
November 2012. The JSHS was initially designed to recruit
850 participants until 2011, based on power calculation
for detecting risk factors or predictors of vascular struc-
tural changes, such as increased arterial wall thickening.
However, we recruited only 830 participants until 2011
and attrition at first follow-up was higher than expected.
Thus, we extended the recruitment period until 2012.
Finally, of the total 1115 available first-year students,
1071 students agreed to participate and completed all
physical examinations, blood laboratory tests and self-re-
ported questionnaires. The overall response rate was
96.1%, although it gradually decreased over the enrolment
period: 99.7%, 98.2%, 94.7% and 91.3% for the 2007,
2010, 2011 and 2012 subcohorts, respectively (Table 1).
The JSHS cohort has a narrow age distribution because
it was restricted to the first-year students. At baseline,
0.4% were 14 years old, 58.2% were 15 years old, 41.3%
were 16 years old and 0.2% were 17 years old. Among the
1071 participants, 52.0% were male and 48.0% were fe-
male. Although study participants were recruited from a
single high school, their anthropometric and blood pres-
sure distributions were similar to those in the Korean
National Growth Charts.23 Cigarette smoking (males
8.1%; females 0.6%) and alcohol drinking (males 10.8%;
females 5.1%) were uncommon in this cohort. According
to the Korean Youth Risk Behavior Survey, cigarette smok-
ing (males 16.4%; females 6.9%) and alcohol drinking
(males 23.0%; females 17.5%) were more frequent among
general Korean adolescents of the same age.24
Socioeconomic status of the JSHS cohort seems to be a lit-
tle higher than average. More than half (55%) of the JSHS
students reported that their fathers were educated for more
than 12 years, whereas the corresponding rate was 44% in
the Korean Youth Risk Behavior Survey.24 Allergic rhinitis
(28.6%), atopic dermatitis (16.9%), and allergic eye dis-
ease (12.0%) were the most common chronic conditions of
the JSHS participants. The study protocol was approved
by the Institutional Review Board of Severance Hospital at
Yonsei University College of Medicine (Approval No.
4-20100169). Written informed consent was obtained
from each participant as well as from his/her parent or
guardian. Informed consent forms were distributed to eli-
gible students at least 1 week prior to the examination, so
Table 1. Number of participants at baseline and follow-up
examinations in the JSHS
Year of
enrolment
Baseline examination First follow-up
examination
Eligible
population
Participants
(response rate)
Participants
(follow-up rate)
2007 286 285 (99.7%) 253 (88.8%)
2010 282 277 (98.2%) 208 (75.1%)
2011 283 268 (94.7%) 209 (78.0%)
2012 264 241 (91.3%) 214 (88.8%)
Total 1115 1071 (96.1%) 884 (82.5%)
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the participating students and their parents had enough
time to understand the purpose and process of the study.
How often have they been followed up?
All cohort members were enrolled for baseline examination
during their first year in high school, and were asked to take
the first follow-up examination during their third year in
high school, usually after completing their scholastic apti-
tude test for college admission. Participants enrolled in 2007
through 2012 completed the first follow-up examination
after 30 months on average, and the follow-up rate was
80.7% (670 of 830). Participants enrolled in 2012 com-
pleted the first follow-up examination after 24 months, but
their follow-up data are not yet analysed. Among the 160
participants who did not participate in follow-up examin-
ation, 20 transferred to other schools and the remaining 140
expressed no intention to continue to participate. The first
follow-up examination includes anthropometric measure-
ments, blood pressure measurements, fasting blood analysis,
carotid ultrasonography, radial pulse wave analysis and self-
administered questionnaires on health-related lifestyle, per-
sonal and family disease history and depression score.
Among male participants, those who were lost to follow-up
tended to weigh more (67.8 kg vs 64.5 kg; P¼ 0.027), be cig-
arette smokers (13.5% vs 4.8%; P¼ 0.017), exercise less fre-
quently (76.4% vs 88.4%; P¼ 0.020) and have higher
carotid intima-media thickness (0.597 mm vs 0.569 mm;
P¼0.001) at baseline, compared with those who were re-
tained (Table 2). However, between lost and retained female
participants, no significant difference was observed in an-
thropometric measures, health behaviours or cardiovascular
risk factors. Therefore, effects of bias due to differential loss
to follow-up should always be considered, especially when
Table 2. Selected baseline characteristics for those who participated in follow-up examination and those who did not
Baseline characteristics Male, n¼424 P Female, n¼406 P
Participants,
n¼335
Non-participants,
n¼89
Participants,
n¼335
Non-participants,
n¼71
Anthropometrics
Age, years 15.86 0.3 15.96 0.3 0.141 15.860.3 15.96 0.3 0.060
Height, cm 171.16 5.4 172.165.2 0.144 160.06 5.0 158.865.1 0.062
Weight, kg 64.56 10.3 67.86 12.7 0.027 54.167.3 53.86 7.1 0.783
Waist circumference, cm 74.06 8.1 75.16 9.0 0.251 69.366.7 69.26 7.2 0.909
Health behaviours
Smoking 16 (4.8) 12 (13.5) 0.017 3 (0.9) 0 (0.0) 1.000
Alcohol drinking 39 (11.6) 12 (13.5) 0.839 16 (4.8) 3 (4.2) 1.000
Regular exercise 296 (88.4) 68 (76.4) 0.020 268 (80.0) 55 (77.5) 0.435
Known diseases
Hypertension 5 (1.5) 1 (1.1) 0.084 1 (0.3) 0 (0.0) 0.620
Chronic gastritis 2 (0.6) 0 (0.0) 0.199 2 (0.6) 0 (0.0) 0.751
Chronic bronchitis 2 (0.6) 1 (1.1) 0.236 3 (0.9) 1 (1.4) 0.422
Allergic rhinitis 102 (30.4) 24 (27.0) 0.852 82 (24.5) 24 (33.8) 0.268
Atopic dermatitis 44 (13.1) 11 (12.4) 0.655 65 (19.4) 11 (15.5) 0.768
Allergic eye disease 36 (10.7) 7 (7.9) 0.552 43 (12.8) 7 (9.9) 0.777
Blood pressure
SBP, mmHg 112.66 11.8 114.3613.1 0.238 102.76 9.9 102.7613.1 0.977
DBP, mmHg 59.46 6.9 60.36 6.9 0.237 59.366.7 58.36 7.8 0.242
Pulse rate, per min 74.06 11.4 72.36 11.8 0.221 75.8610.0 74.46 11.1 0.309
Fasting blood analysis
HbA1c, % 5.296 0.25 5.296 0.25 0.896 5.2560.25 5.296 0.26 0.213
Cholesterol, mg/dl 148.26 26.7 147.1620.8 0.672 160.96 25.7 161.0623.0 0.962
TG, mg/dl 83.16 31.1 84.66 31.7 0.689 78.3626.9 79.66 24.8 0.708
HDL, mg/dl 41.46 8.6 41.06 7.7 0.677 47.669.4 46.16 8.2 0.225
CRP, mg/l 0.36 [0.14–0.87] 0.29 [0.15–0.79] 0.795 0.19 [0.10–0.58] 0.26 [0.10–0.57] 0.234
Carotid ultrasonography
Intima-media thickness, mm 0.5696 0.058 0.59760.070 0.001 0.5356 0.114 0.51360.092 0.092
Data expressed as mean6 SD, number (percent), median [25th to 75th percentiles].
Only 830 participants who were enrolled in 2007, 2010 and 2011 were compared.
TG, total trigycerides.
International Journal of Epidemiology, 2017, Vol. 46, No. 2 395
analysing the effects of behavioural risk factors. Moreover, it
should be kept in mind that the reasons for and impacts of
follow-up loss may differ between male and female
adolescents.
The second follow-up examinations are added after 7 to
10 years after the baseline examinations. To minimize loss
to follow-up, the JSHS Study will maintain regular personal
contact through phone calls, e-mails, and post mail. We also
got permission from each participant to use their identifica-
tion number for linkage to nationwide health databases,
including the National Health Insurance Claim Database,
National Cancer Registry and Causes of Death Statistics.
What has been measured?
Data have been collected through self-reported question-
naires, interviews, physical examinations and laboratory
tests according to predetermined protocol. Table 3 shows
the list of questionnaire-based measurements, physical
examinations and laboratory tests according to year of en-
rolment. For all subcohorts, baseline measurements include
anthropometry, resting blood pressure, electrocardiogram,
fasting blood analysis, carotid ultrasonography and ques-
tionnaires on health-related lifestyle, medical history, fam-
ily history of major disorders, and depressive symptoms.
Fasting blood analysis includes blood counts, liver en-
zymes, glucose and lipid profiles, and inflammatory
markers. Carotid artery ultrasonography was performed to
evaluate structural vascular change by measuring intima-
media thickness and presence of plaque. In addition to the
above-mentioned core measurements, pulmonary function
tests have been conducted for 2007, 2010 and 2011 subco-
horts; radial pulse wave analysis has been conducted for
2010 and 2011 subcohorts, and body composition analysis
has been conducted for 2011 and 2012 subcohorts.
The protocol of the baseline measurement is summar-
ized as follows. A questionnaire was distributed to eligible
students at least 1 week before the examination.
Participants were asked about their demographic factors,
health behaviours, medical history, family history and de-
pressive symptoms. Demographic factors included parents’
education, marriage, household income and occupation.
Health behaviours included cigarette smoking, alcohol con-
sumption and physical activity. Medical history included
previous diagnosis of hypertension, dyslipidaemia, tubercu-
losis, chronic gastritis, ulcer, diabetes, liver disease, chole-
lithiasis, chronic bronchitis, depressive disorder, cancer or
allergic diseases. Family history included diagnosis of or
deaths from hypertension, diabetes, ischaemic heart dis-
ease, stroke and cancer among the participant’s parents and
siblings. Symptoms of depression were assessed using the
21-item Beck Depression Inventory.25
Anthropometric measures, performed using the same
devices throughout this study, were taken by a trained
examiner. Standing height was measured to the nearest
0.1 cm on a stadiometer and body weight was measured to
the nearest 0.1 kg on a digital scale (Seca 763; SECA,
Hamburg, Germany) while wearing the school uniform.
Waist circumference was measured to the nearest 0.1 cm at
the level of the superior iliaccrest at the end of a normal
expiration. Resting blood pressure and pulse rate were
measured with an automated oscillometric device
(Dinamap1846 SX/P; GE Healthcare, Waukesha, WI,
USA). Participants were seated in the examination room
for at least 5 min before blood pressure measurement and
then an appropriately sized cuff was applied snugly around
the right upper arm at heart level. Two readings at 5-min
intervals were obtained and averaged to determine systolic
blood pressure (SBP) and diastolic blood pressure (DBP)
for each individual. When the two readings differed or
more, additional readings were obtained after 5 min and
the last two readings were averaged. Electoricardiography
(ECG) was performed in the supine position using a
standard 12-lead ECG machine (PageWriter Trim III
Cardiograph, Eindhoven, The Netherlands). An overnight
fasting blood sample was collected after at least an 8-h
fast. Collected blood samples were processed, refrigerated
immediately, transported in cold storage to the central la-
boratory, and analysed within 24 h. Measured blood bio-
markers include complete blood counts, protein, albumin,
urea nitrogen, creatinine, aspartate and alanine amino-
transferases, gamma-glutamyltransferase, total bilirubin,
glucose, insulin, HbA1c, total cholesterol, triglycerides,
high-density lipoprotein (HDL) cholesterol and C-reactive
protein. Carotid artery intima-media thickness (IMT) and
the presence of plaque in both the left and right carotid
arteries were assessed with high-resolution B-mode ultra-
sound scanning imaging (SSAD-3500SV; Aloka, Tokyo,
Japan).
Pulmonary function testing was performed by trained
technicians using a volume displacement spirometer
(model 1022; Sensor Medics; Yorba Linda, USA). After in-
struction and a practice attempt, each subject performed a
minimum of three (maximum of eight) forced expiratory
manoeuvres to provide estimates of forced vital capacity
(FVC), forced expired volume in one second (FEV1), FEV1/
FVC and forced expiratory flow between 25–75% (FEF
25–75). Radial artery pulse was analysed using an auto-
mated radial pulse waveform analyser (HEM-9000AI,
Omron Healthcare, Kyoto, Japan) to estimate augmenta-
tion index and central systolic blood pressure. Bone min-
eral density was measured at the right forearm and
calcaneus (heel) using mobile X-ray bone densitometry
(EXA-3000, Osteosys, Seoul, Korea). Body composition
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data, including body fat mass, percent body fat, lean mass,
fat-free mass, skeletal muscle mass and appendicular fat-
free mass, were estimated using a bioelectric impedance
analyser (InBody 370, Biospace, Seoul, Korea).
What has it found?
Baseline characteristics of the study participants are sum-
marized in Table 4. Mean age of the participants was 15.9
years for male (n¼ 557) and female (n¼514) participants
Table 3. Summary of questionnaire, physical examinations and laboratory tests in the JSHS
Variables Sub-cohort by year of enrolment
2007 2010 2011 2012
Baseline Follow-up Baseline Follow-up Baseline Follow-up Baseline Follow-up
Demographic factors
Date of birth X X X X X X X X
Parents’ education X X X X X X X X
Parents’ marriage X X X X X X X X
Parents’ household income X X X X X X X X
Parents’ occupation X X X X X X X X
Health behaviours
Cigarette smoking X X X X X X X X
Alcohol consumption X X X X X X X X
Physical activity X X X X X X X X
Depressive symptoms X X X X X X X X
Medical history X X X X X X X X
Family history X X X X X X X X
Menstruation history
Age at menarche X X X X X X X X
Regularity of menstruation X X X X X X X X
Duration of menstrual flow X X X X X X X X
Anthropometrics
Body weight X X X X X X X X
Standing height X X X X X X X X
Waist circumference X X X X X X X X
Hip circumference X X X X X X X X
Thigh circumference X X X X X X X X
Skinfold thickness X X X X
Body composition analysis X X X X X
Blood pressure X X X X X X X X
Radial pulse analysis X X
Bone mineral density X X X X X X
Electrocardiography X X X X
Pulmonary function test X X X
Carotid ulatrosoundgraphy X X X X X X X X
Fasting blood sample
Group A X X X X X X X X
Group B X X X X
Group C X X X X X
Group D X X X
Depressive symptoms: back’s Depression Inventory (BDI)-I.
Medical history: physician-diagnosed, hypertension, dyslipidaemia, tuberculosis, chronic gastritis, gastric ulcer, diabetes, liver disease, chole-
lithiasis, chronic bronchitis, depressive disorder, cancer, allergic diseases.
Family history: diagnosis or death among parents and siblings, hypertension, dyslipidaemia, ischaemic heart disease, stroke, diabetes, cancer.
Group A: haemoglobin, white blood cells, red blood cells, haematocrit, mean corpuscular volume (MCV), mean corpuscular hemoglobin
(MCH), mean corpuscular hemoglobin concentration (MCHC), platelets, protein, albumin, blood urea nitrogen, creatinine, total bilirubin, aspar-
tate aminotransferase, alanine aminotransferase, gamma-glutamyltransferase, glucose, insulin, haemoglobin A1c, total cholesterol, triglycerides,
high-density lipoprotein cholesterol and C-reactive protein.
Group B: fibrinogen and fibrin d-dimer.
Group C: serum 25(OH)D and calcium.
Group D: leptin, osteocalcin, osteprotegerin and parathyroid hormone.
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Table 4. Distribution of selected baseline characteristics in the JSHS
Variables Total (n¼1071) Male (n¼557) Female (n¼514)
Anthropometrics
Age, years 15.96 0.4 15.96 0.4 15.960.4
Height, cm 165.967.8 171.56 5.2 159.76 5.0
Weight, kg 60.06 10.7 65.36 10.6 54.367.4
BMI, kg/m2 21.76 3.0 22.26 3.2 21.362.6
Waist circumference, cm 71.26 7.9 73.66 8.1 68.666.7
Hip circumference, cm 93.96 5.9 94.46 6.5 93.365.2
Thigh circumference, cm 50.76 5.1 51.56 5.2 49.964.9
Health behaviours
Smoking 48 (4.5) 45 (8.1) 3 (0.6)
Alcohol drinking 86 (8.1) 60 (10.8) 26 (5.1)
Regular exercise 836 (78.2) 473 (85.2) 363 (70.6)
Prevalent diagnoses
Hypertension 9 (0.8) 8 (1.5) 1 (0.2)
Chronic gastritis 6 (0.6) 3 (0.5) 3 (0.6)
Chronic bronchitis 11 (1.0) 6 (1.1) 5 (1.0)
Allergic rhinitis 304 (28.6) 170 (30.7) 134 (26.2)
Atopic dermatitis 180 (16.9) 79 (14.3) 101 (19.7)
Allergic eye disease 128 (12.0) 60 (10.8) 68 (13.3)
Blood pressure
Systolic blood pressure, mmHg 109.8613.0 115.16 12.8 104.06 10.6
Diastolic blood pressure, mmHg 60.86 7.6 61.46 7.8 60.267.4
Pulse rate, per min 74.76 10.7 73.46 11.0 76.1610.2
Carotid ultrasonography
Intima-media thickness, mm 0.55360.084 0.5726 0.06 0.5346 0.101
Fasting blood analysis
Haemogbin, g/dl 14.36 1.3 15.36 0.8 13.360.9
Haematocrit,% 44.36 4.3 47.56 2.8 40.962.7
RBC, Mil/UI 4.886 0.43 5.186 0.32 4.5660.27
WBC, Th/Ul 7.026 1.90 6.956 1.87 7.1061.94
Platelet, Th/Ul 264.5656.6 261.56 58.3 267.86 54.6
Glucose, mg/dl 87.26 7.1 88.26 7.1 86.266.9
Insulin, uIU/ml 8.626 3.13 8.636 3.29 8.6262.94
HbA1c, % 5.256 0.24 5.266 0.24 5.2560.24
Cholesterol, mg/dl 155.3626.3 148.76 24.6 162.56 26.2
TG, mg/dl 80.56 30.2 82.16 31.3 78.7628.9
HDL, mg/dl 46.96 10.8 44.26 10.0 49.9610.9
Protein, g/dl 7.726 0.34 7.736 0.35 7.7260.34
Albumin, g/dl 4.886 0.22 4.960.2 4.8560.23
BUN, mg/dl 13.06 2.7 13.66 2.7 12.462.6
Creatinine, mg/dl 0.926 0.11 1.006 0.09 0.8460.07
Bilirubin, mg/dl 0.906 0.34 0.936 0.35 0.8660.33
ALT, IU/l 14 [12 to18] 17 [13 to 21] 12 [11 to 15]
AST, IU/l 20 [17 to 22] 21 [19 to 23] 18 [16 to 21]
c-GTP, IU/l 12 [11 to 16] 14 [11 to 18] 12 [10 to 14]
CRP, mg/l 0.30 [0.14 to 0.70] 0.35 [0.17 to 0.77] 0.26 [0.12 to 0.61]
Data expressed as mean6 standard deviation, number (percent), or median [25th to 75th percentiles].
Smoking, 100 cigarettes in life; drinking, 1 time/month; exercise, 1 time/week; RBC, red blood cells; WBC, white blood cells; HbA1C, haemoglobin A1c;
cholesterol, total cholesterol; TG, triglycerides; BUN, blood urea nitrogen; bilirubin, total bilirubin; ALT, alanine aminotransferase; AST, aspartate amiotansfer-
ase, c-GTP, c-glutamyl transpeptidase; CRP, C-reactive protein.
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at baseline. Male participants were more likely to smoke
cigarettes, drink alcohol and exercise regularly, compared
with female participants. Height, weight, SBP and carotid
IMT were relatively higher in male participants, whereas
body fat mass was higher in female participants. Analyses
for the first follow-up examinations are ongoing.
Currently, the main results to date of the JSHS are sum-
marized as follows.
First, a cross-sectional analysis for the 2007 subcohort
showed that higher blood pressure levels may be associated
with increased carotid IMT (Figure1).26 Adjusted odds
ratios for increased IMT were 1.70 (P¼ 0.003) per
12.4 mmHg SBP and 1.25 (P¼0.125) per 7.0 mmHg DBP.
When the analyses were performed by sex, increased IMT
was associated with both SBP (odds ratio, 2.67; P¼ 0.003)
and DBP (odds ratio, 1.68; P¼ 0.019) in females, but not
with either SBP (odds ratio, 1.46; P¼ 0.093) or DBP (odds
ratio, 0.99; P¼ 0.972) in males.26 Second, another cross-
sectional study showed that higher pulse pressure may be
associated with increased carotid IMT (Figure 2).27 There
was a significant correlation between pulse pressure
and carotid IMT before (Pearson coefficient r¼ 0.204;
Figure 1. Risk for increased carotid intima-media thickness according to blood pressure level.
Figure 2. Relationships between pulse pressure and carotid intima-media thickness (IMT) in adolescents.
Adjusted for age, waist circumference, fasting plasma glucose, and total/HDL cholesterol ratio.
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P¼ 0.001) and after (r¼ 0.148; P¼ 0.020) adjustment for
sex. When adjusted for sex, age, waist circumference, fast-
ing blood glucose and total/high-density lipoprotein chol-
esterol ratio, a 10-mmHg increase in pulse pressure was
associated with increase of IMT in the overall cohort
(P¼ 0.003) and in males (P< 0.001), but not in females
(P¼ 0.518).27 Third, study of the 2011 subcohort showed
that serum 25-hydroxy vitamin D [25(OH)D] level may be
inversely associated with insulin resistance (Figure 3).28 In
males, every 10-ng/ml decrease in 25(OH)D level was asso-
ciated with a 0.25-unit increase in the homeostatic model
assessment insulin resistance index (HOMA-IR)
(P¼ 0.003) after adjusting for age and BMI. Compared
with those in the highest quartile, males in the lowest
25(OH)D quartile were at significantly higher risk for insu-
lin resistance: unadjusted odds ratio of 4.06 [95% confi-
dence interval (CI), 1.26 to 13.07]; age- and BMI-adjusted
odds ratio 3.59 (95% CI, 1.03 to 12.57). However,
25(OH)D level was not significantly associated with insu-
lin resistance among females.28
What are the main strengths and
weaknesses?
The JSHS employed a prospective design at the beginning
of this study, aimed at following up adolescence into adult-
hood; (i) this cohort will yield on the association between
major cardiovascular risk factors and vascular alterations
at the stage of adolescence; and (ii) baseline and follow-up
data will be analysed to investigate tracking phenomena of
cardiovascular risk factors from adolescence to adulthood,
and the effects of adolescent risk factors on adulthood vas-
cular disease. The JSHS is, therefore, expected to make an
important contribution to theory and model formation in
research on adolescent and adult health.
One of the weaknesses of this study is the relatively
small sample size. This study was designed to achieve
enough statistical power to identify risk factors for inter-
mediate phenoptypes or subclinical atherosclerosis. Thus,
it may not observe a sufficient number of clinical cardio-
vascular events for these to be studied appropriately. In
addition, the study findings may have some limitations in
terms of generalizability as some of the sociodemographic
factors and health behaviours of the participants differed
from those of the general population of Korean adoles-
cents. However, body size and blood pressure of the study
participants were similar to those from national represen-
tative data.
Can I get hold of the data? Where can I find
out more?
The JSHS is being conducted mainly at the Department of
Preventive Medicine, Yonsei University College of
Medicine, Seoul, Korea, which is responsible for the collec-
tion, the management and distribution of the data. Further
Figure 3. Serum 25(OH)D level and the risk of increased insulin resistance.
Defined as homeostasis model assessment insulin resistance  75 percentile value (male, 2.09; female, 1.99). Adjusted for age, body mass index,
smoking, drinking, and regular exercise.
*P<0.05.
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information can be requested by e-mailing the principal in-
vestigator [hckim@yuhs.ac].
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